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1. Introduction
The design of interpolymeric complexes, which can
be used for the immobilization of various drugs,
hormones, enzymes, and proteins is of considerable
interest because of the possibility of developing
different controlled release systems.
Polysaccharides have several advantages as com-
ponents in drug delivery systems. They are natural
or semi-synthetic polymers showing a good bio-
compatibility with living cells. Blend of polysac-
charides with synthetic water-soluble polymers
lead to materials with improved physico-chemical
and mechanical characteristics [1].
Several reports were devoted to the development of
various drug dosage forms based on poly(car-
boxylic acid)-polysaccharide compositions indicat-
ing good results in the release of morphine sulfate
[2], propranolol hydrochloride [3], carbamazepin
[4], model peptide peroxidase [5], lidocaine [6]
amoxillin and rifampicin, insulin [7], levomycetin
[8, 9], proteins, lactate dehydrogenase [10],
phenacetin [11], timolol maleate for ophthalmol-
ogy application [12], antibacterial agent, ofloxacin
[13] and many others. Most formulations were ther-
apeutically efficacious, stable, and nonirritant [14].
The complexes based on poly(acrylic acid), PAA
and methyl or hydroxypropyl methyl cellulose
demonstrated very good ability to form capsules
insoluble in acid media [15].
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Abstract. Poly(carboxylic acid)-polysaccharide compositions have been found suitable for obtaining drug formulations
with controlled release, most formulations being therapeutically efficacious, stable, and non-irritant. The influence of the
characteristics of the aqueous solutions from which the polymer matrix is prepared (i.e. the total concentration of polymer
in solutions and the mixing ratio between the partners, hydroxypropyl cellulose, HPC and maleic acid-alternating-styrene
copolymer, MAc-alt-S) on the kinetics of some drugs release in acidic environment (pH = 2) has been followed by ‘in
vitro’ dissolution tests. It has been established that the kinetics of procaine hydrochloride release from HPC/MAc-alt-S
matrix depends on its composition; the diffusion exponent, n is close to 0.5 for matrices where one of the components is in
large excess and n~0.02 for middle composition range. The lower value of diffusion exponent for middle composition
range could be caused by the so called ‘burst effect’, therefore the kinetic evaluation is difficult.
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DOI: 10.3144/expresspolymlett.2009.36Satoh and co-workers [16] studied the bioadhesive
properties of tablets consisting of hydroxypropyl
cellulose (HPC) and carboxyvinyl polymer (CP)
using mouse peritoneal membrane containing
bleomycin hydrochloride, carboquone, and 5-fluo-
rouracil and they found them favorable for the
treatment of foci in the cervical canal.
In a previous work we showed that HPC and MAc-
alt-S copolymer form interpolymeric complexes,
IPC via hydrogen bonding interactions between the
oxygen of the ether groups of HPC and the OH-
groups of the carboxyl groups of MAc-alt-S
[17, 18], IPC stabilized by hydrophobic interac-
tions between the isopropyl side chain of HPC and
the styrene groups of MAc-alt-S [19]. The stoi-
chiometry of the interpolymeric complex was esti-
mated to be HPC/MAc-alt-S = 40:60 [w/w]
independent of the total polymer concentration in
the system, cpol. At cpol = 5 mg·ml–1, the mixtures
with a content of HPC in the initial mixtures
between 20 and 60 wt%, phase separate. At
cpol = 10 mg·ml–1, depending on the mixing ratio
between the partners, either a phase separation (in
the mixtures with a prevailing content of one of the
components) or a gelation (similar mixing ratio
between components) occurs. The IR spectra indi-
cated that there is a tendency of the MAc-alt-S,
independent of the mixing ratio of the components,
to accumulate in the gel until it reaches a concentra-
tion of around 60 wt%. The maximum concentra-
tion of the precipitate in the gel phase is also
reached at a mixing ratio between HPC and MAc-
alt-S of 40/60 that corresponds to the stoichiometry
of the complex. At pH lower than 4.5 the HPC/
MAc-alt-S, IPC becomes water-insoluble [18].
It is well known from membrane science that the
morphology and therefore the permeability and
transport characteristics highly depend on the way
of preparation [20]. Also in mixtures that can form
IPCs, it is expected that when one of the compo-
nents is in large excess, the structure of the inter-
polymer associations to be different to the mixtures
where the ratio between the components is close to
the stoichiometry, therefore a different morphology
and release profile of the drug is expected.
In this work, it is investigated the influence of the
characteristics of the aqueous solutions from which
the polymer matrix is prepared, i.e. the total con-
centration of polymer in solutions and the mixing
ratio between the partners, hydroxypropyl cellulose
and maleic acid-alternating-styrene copolymer, on
the kinetics of the various drugs released in acidic
environment (pH = 2). Three drugs with different
structure, molecular weight and solubility have
been incorporated in the HPC/MAc-alt-S matrices,
namely: procaine hydrochloride, vanillin and tan-
nic acid.
Procaine hydrochloride, known also as novocaine,
it is a local anaesthetic from the amino ester group,
mainly used to reduce the pain of intramuscular
infections, in stomatology, etc. It acts by constric-
tion of blood vessels determining the bleeding
reduction without generating a euphoric state or
dependence. Procaine blocks the generation and
transmission of the nervous impulses by lowering
the membrane permeability to the ions, inhibiting
the depolarization and so loosing of pain sensation.
Procaine is also the main ingredient in the prepara-
tion of the Gerovital H3 known to slow down the
aging effects. From theoretical point of view pro-
caine is often used as model drug in many drug
release experiments.
Vanillin (4-hydroxy-3-methoxybenzaldehyde) is
efficacious for the treatment of chronic hypoacidic
gastritis and chronic non-acid gastritis. As well as
this receptor inhibition, in the central nervous sys-
tem, vanillin also influences the craving to con-
sume food. In this context it is supposed that the
vanillin is able to increase the concentration of the
neurotransmitter serotonin in the brain [21].
Increased brain serotonin concentration, however,
leads demonstratively to a reduced craving to con-
sume food.
Tannic acid can be used for medical purposes such
as: anti-diarrhoea, hemostats and anti-piles com-
pounds, while together with other related com-
pounds as those containing galic and elagic acids
(epigalitaninuri) are inhibitors in HIV replications.
It has anti-bacterial properties and is a very benefi-
cial anti-oxidant. In high quantities it slows down
the absorption of iron and possibly other trace min-
erals. The use of tannic acid as an adjuvant therapy
for burn wounds has regained interest in present
times. In particular, some preclinical and clinical
studies indicate that highly purified tannic acids
can provide a valuable tool to improve wound heal-
ing and to reduce scar tissue formation, it induces a
durable, supple crust that did not obstruct the regu-
lar outgrowth of epithelium. The assumed hepato-
toxicity of tannic acid is questioned [22].
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2.1. Materials
Hydroxypropyl cellulose LF, Klucel™, a food grade
polymer, offered by courtesy of Aqualon Com-
pany, Hopewell, Virginia has been used. According
to the producer specifications, HPC LF has a
molecular mass of approximately 100 000 g·mol–1
and a 3.4 moles of substitution [23]. The main
chain of HPC consists of glucopyranosyl units
linked in (1 → 4) β position. The side substituents
are formed by short chains containing from one up
to six hydroxypropyl units.
Maleic acid-alternating-styrene copolymer (MAc-
alt-S) was prepared by the hydrolysis of maleic
anhydride-alternating-styrene copolymer (MA-
alt-S) in pure water, at 80°C for 4 h. MA-alt-S has
been synthesized by free radical copolymerizations,
in toluene, at 80°C (the detailed synthesis has been
described in ref. [24]). The molecular mass of the
MAc-alt-S copolymer was calculated based on the
molecular mass of the MA-alt-S copolymer as
being 130 000 g·mol–1, considering that there are
no changes in chain length during hydrolysis. The
MAc-alt-S copolymer is totally water-soluble.
Both samples (HPC and MAc-alt-S copolymer)
were carefully purified before study by dialysis
against water and then freeze dried.
The structure and the water solubility of the used
drugs are summarized in Table 1.
Twice-distilled water was used as solvent for all
measurements. The pH of the solutions was
adjusted at value 2 with diluted HCl solution in
twice-distilled water.
Procaine hydrochloride, vanillin and tannic acid
were purchased from Sigma Aldrich and used as
received.
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Table 1. Characteristics of the used drugs
*Science Laboratories, http://www.sciencelab.com/xMSDS-Procaine_hydrochloride-9924715;
Mallinckrodt Baker Inc. Materials safety data sheet
**http://www.jtbaker.com/msds/englishhtml/v2775.htm
***http://www.jtbaker.com/msds/englishhtml/t0065.htm
Drug Structure
Water solubility
[mg/l]
Procaine
hydrochloride
9450
Easily soluble in cold
water*
Vanillin
10000
Soluble in 125 parts
water**
Tannic acid
Completely soluble:
1 g/0.35 ml water***2.2. Preparation of the IPC/drug systems
The drugs were incorporated in the polymeric
matrix of HPC, MAc-alt-S or their mixtures at dif-
ferent mixing ratios, at a weight ratio between
matrix and drug of 4 to 1. As MAc-alt-S forms a
precipitate with procaine hydrochloride, the sam-
ples were prepared as followed: the corresponding
amount of drug was previously dissolved in the
aqueous solution of HPC and then the HPC-drug
solution was mixed with the aqueous solution of
the MAc-alt-S in different mixing ratios. The
obtained samples were frozen at –50°C and freeze-
dried.
The polymer matrix was prepared at the following
weight mixing ratios between HPC and MAc-alt-S:
10/90, 40/60, 50/50, 80/20 at two different total
polymer concentrations cpol = 5 mg/ml and cpol =
10 mg/ml.
For comparison reasons the same preparation pro-
cedure was used to incorporate vanillin and tanic
acid in the 40 wt% HPC/60 wt% MAc-alt-S matrix
at cpol = 10 mg/ml.
2.3. Sample characterization
A Leitz Wetslar microscope, Germany was used to
investigate the fluorescence behaviour of the sam-
ples at a magnification of 250×.
In vitro release studies have been conducted in a
standard dissolution set-up. [25] Aliquots of the
medium of 1 ml were withdrawn periodically at
predetermined time intervals and analyzed using a
Hewlett Packard 8540A spectrophotometer. In
order to maintain the solution concentration the
sample is reintroduced in the circuit after analyzing.
The concentrations of the drug were calculated
based on previously measured calibration curves
for each drug at their specific maximum absorption
wavelengths using solutions of known concentra-
tions in the range of loaded drug. The maximum
absorption wavelengths at pH = 2 are for procaine
hydrochloride at λmax = 292 nm, vanillin at λmax =
229 nm and tannic acid at λmax = 212 nm.
A simple, semi-empirical equation using Higuchi
model was used to analyze kinetically the data
regarding the drug release from HPC/MAc-alt-S
system at the initial stages (approximately 60%
fractional release) [26–32] (Equation (1)):
(1)
where Mt/M∞ is the fractional drug release; Mt and
M∞ are the absolute cumulative amounts of drug
released at time t and at infinite time (in this case
maximum release amount in the experimental con-
ditions used, at the plateau of the release curves),
respectively; kH is the Higuchi dissolution constant
that incorporates the characteristics of the macro-
molecular network system and the drug, and n is
the diffusional exponent, which is an indicative of
the transport mechanism.
It has been established that for n = 0.5, the release
mechanism follows the Fick’s law diffusion. A
value of n = 1, it means that the drug release is
independent of time, while when n lies between 0.5
and 1 an anomalous transport is involved [27, 33].
3. Results and discussion
The matrices do not exhibit fluorescence or it is
very weak for the MAc-alt-S copolymer. In fluo-
rescence microscopy the colour depends on the
drug type being brown-to-green for procaine
hydrochloride (Figure 1a) transparent-to-light
green for vanillin (Figure 1b) and dark-brown-to-
dark blue (Figure 1c) for tannic acid and the aspect
(Figures 1a to 1c) indicates a homogenous distribu-
tion of the drugs in the matrix.
3.1. Influence of the drug type
The release profile of the three drugs, procaine
hydrochloride, vanillin, and tannic acid, with dif-
ferent solubility or size from a HPC/MAc-alt-S
interpolymeric associations matrix was investi-
gated at pH = 2 and T = 37°C, an environment that
simulate the physiological conditions in the stom-
ach, Figure 2. The matrix has a composition of
40HPC/60MAc-alt-S and it was prepared form a
solutions with cpol = 5 and 10 mg/ml. The maxi-
mum released quantity at pH = 2 is lower (~38%)
when concentration was 5 wt% in respect with the
case when concentration was 10% (~58%), while
the release time decreased with increasing concen-
tration. These values depend on the composition of
HPC/MAc-alt-S. The kinetic values are evaluated
for approximately 60% of drug released.
n
H
t t k
M
M
=
∞
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released the fastest from the matrix, while the
vanillin was the slowest. The equilibrium values of
the fractional release are reached after only 14 min-
utes for procaine hydrochloride while for tannic
acid this value is reached after ca. 47 minutes, and
vanillin needs about 190 minutes.
The kinetic data obtained by analysing the drug
release profile according to Equation (1) are col-
lected in Table 2.
Tannic acid and vanillin have similar release order,
therefore similar transport mechanisms. The data
for procaine hydrochloride are difficult to analyse,
as the release of the drug is very fast. It is character-
ized by a pronounced ‘burst effect’.
3.2. Influence of matrix composition on the
release profile
The fractional release of procaine hydrochloride
from matrices with different ratios between HPC
and MAc-alt-S is shown in Figures 3a and 3b
The release profile of the drug depends both on the
ratio between the HPC and MA-alt-S and on the
total polymer concentration of the solutions used
for the preparation of matrix. For example for the
matrix containing 80HPC/20MAc-alt-S the release
time decreases from 175 minutes when the system
is prepared from a solution with cpol = 5 mg/ml to
100 minutes when it is obtained form cpol =
10 mg/ml, while for the matrix 50HPC/50MAc-
alt-S, these values are 60 and 20 min, respectively.
Procaine hydrochloride releases much faster from
matrices with a composition close to the stoichiom-
etry of the IPC than from matrices where one of the
components are in excess. For example for the
matrix containing 40HPC/60MAc-alt-S the plateau
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Figure 1. a) Microscopical aspects of the 40HPC/60MAc-
alt-S/procaine hydrochloride system prepared
form both a solution with a cpol = 5 mg/ml and
cpol = 10 mg/ml in fluorescence light at various
wavelengths of excitation: (I) white light,
(II) 380 nm, (III) 410 nm and (IV) 440 nm.
b) Microscopical aspects of the 40HPC/60MAc-
alt-S/vanillin system prepared form a solution
with a cpol = 10 mg/ml in fluorescence light at
various wavelengths of excitation: (I) white
light, (II) 380 nm, (III) 410 nm and (IV) 440 nm.
c) Microscopical aspects of the 40HPC/60MAc-
alt-S/tannic acid system prepared form a solu-
tion with a cpol = 10 mg/ml in fluorescence light
at various wavelengths of excitation: (I) white
light, (II) 380 nm, (III) 410 nm and (IV) 440 nm
Figure 2. Release profiles of procaine hydrochloride, tan-
nic acid, and vanillin from a 40HPC/60MAc-
alt-S matrix at pH = 2 and T = 37°C
Table 2. Values of n and kH for various drugs released from
a 40HPC/60MAc-alt-S matrix at pH = 2 and
T = 37°C
Drug n kH [min–n]
Tannic acid 0.326 ± 0.008 0.384 ± 0.006
Procaine hydrochloride 0.018 ± 0.007 0.920 ± 0.020
Vanillin 0.351 ± 0.003 0.160 ± 0.001is reached after about 50 minutes while for 80HPC/
20MAc-alt-S it takes about 175 minutes.
The similar values for the release time have been
obtained by other authors from different non-cova-
lent hydrogen bonding or polyionic interpolymeric
complexes. For example using poly(vinyl alcohol)/
poly(acrylic acid), PAA interpolymer complexes
release time of mucosal drug delivery was max. 60
or 30 min [23], PAA/Chitosan (100 min) [34], Chi-
tosan/polyethyleneoxide-maleic acid copolymer
films (max. 50 min) [32]. In the last case for the
polyelectrolyte complex films derived from poly-
ethyleneoxide-maleic acid copolymer, Leong et al.,
found a release time of ibuprofen of maximum
30 min [31]. When entering into intestine, where
pH ~7.4 the H-bonding associations between poly-
mer components and those between drug and poly-
mer matrix are destroyed due to the basic pH and
release rate and amount of the drug released will be
faster and respectively higher [35–37].
The derivatives of the release profile curves, pro-
portional with the rate of drug release, are shown in
Figure 4. All show an exponential decrease with
time up to 75 min then level off.
In the first 30 minutes, the release rate is very fast
for all studied systems, they present the ‘burst
effect’ and then a plateau value is reached for the
entire investigated duration of the release study.
One can notice that the slowest release rates is
given by 10HPC/ 90MAc-alt-S matrix, when the
mixture is prepared form a solution with a
cpol = 5 mg/ml and 80HPC/ 20MAc-alt-S matrix,
respectively when this is prepared from a solution
with a concentration of cpol = 10 mg/ml.
Kinetic analysis of our data is presented in
Figures 5a and 5b and obtained values are given in
Table 3.
The kinetics of procaine hydrochloride release
from HPC/MAc-alt-S matrices depends on their
composition; the diffusion exponent, n is close to
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Figure 3. Release profiles of procaine hydrochloride from HPC/MAc-alt-S matrix for various ratio between components
and different total polymer concentration in the initial solution: (a) cpol = 5 mg/ml and (b) cpol = 10 mg/ml
Figure 4. Derivative curves of the release profiles of pro-
caine hydrochloride from HPC/MAc-alt-S
matrix: a) cpol = 5 mg/ml and b) cpol = 10 mg/ml0.5 for matrix where one of the components is in
large excess and n ~0.02 for middle composition
range. An exception is the diffusional exponent for
the release from pure MAc-alt-S. As it has been
above mentioned, in this case the components form
an insoluble complex.
4. Conclusions
The release profile of the drugs from a system that
can form interpolymer association is influenced by
the mixing ratio between the components and the
total polymer concentration the matrix is prepared
from. For compositions close to the stoichiometry
of the IPC, the release drug rate is faster, while for
pure MAc-alt-S it takes the longest to reach the
plateau. The total polymer concentration of the
HPC/MAc-alt-S solutions influences the procaine
delivery release profile especially for mixture
where one of the components is in excess. The
delivery rate slows down after around 30–40 min-
utes.
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